PERSPECTA

News from every angle

Back to headlines

Bioarctic Leads Alzheimer's Treatment Research, Proposes Dividend

Swedish company Bioarctic, originally an academic research project, has revolutionized Alzheimer's disease treatment and is now proposing a dividend after achieving over 1 billion SEK in net profit.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.